What is the price target for MMM stock?
24 analysts have analysed MMM and the average price target is 177.51 USD. This implies a price increase of 25.72% is expected in the next year compared to the current price of 141.2.
NYSE:MMM • US88579Y1010
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for 3M CO (MMM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-21 | Deutsche Bank | Maintains | Hold -> Hold |
| 2026-01-21 | RBC Capital | Maintains | Underperform -> Underperform |
| 2026-01-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-21 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-21 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-16 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-12-08 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2025-12-04 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-22 | UBS | Maintains | Buy -> Buy |
| 2025-10-22 | RBC Capital | Maintains | Underperform -> Underperform |
| 2025-10-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-22 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-22 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2025-10-15 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-09 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-21 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-09 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-30 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-05-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-23 | RBC Capital | Maintains | Underperform -> Underperform |
| 2025-04-23 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-14 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 24.61B -5.93% | 24.575B -0.14% | 24.948B 1.52% | 25.439B 1.97% | 26.234B 3.13% | 26.952B 2.74% | 28.56B 5.97% | N/A | N/A | N/A | |
| EBITDA YoY % growth | 6.177B 63.07% | 6.372B 3.16% | N/A 9.90% | 7.365B 5.17% | 7.78B 5.63% | 7.859B 1.02% | 8.471B 7.79% | 8.866B 4.66% | N/A | N/A | |
| EBIT YoY % growth | 4.19B 114.10% | 5.009B 19.55% | 4.791B -4.35% | 6.108B 27.49% | 6.535B 6.99% | 6.787B 3.86% | 7.637B 12.52% | 7.866B 3.00% | 7.506B -4.58% | 7.694B 2.50% | |
| Operating Margin | 17.03% | 20.38% | 19.20% | 24.01% | 24.91% | 25.18% | 26.74% | N/A | N/A | N/A | |
| EPS YoY % growth | 9.24 -8.51% | 7.98 -13.64% | 8.06 1.00% | 8.73 8.27% | 9.49 8.73% | 10.07 6.15% | 10.78 7.00% | 11.02 2.25% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.01 6.90% | 2.27 5.31% | 2.39 8.97% | 2.01 9.83% | 2.24 11.57% | 2.44 7.45% | 2.53 5.81% | 2.25 12.06% |
| Revenue Q2Q % growth | 6.106B 5.64% | 6.449B 4.73% | 6.548B 3.64% | 6.352B 5.46% | 6.482B 6.16% | 6.687B 3.69% | 6.753B 3.13% | 6.63B 4.38% |
| EBITDA Q2Q % growth | 1.792B 15.69% | 1.913B 10.51% | 2.01B -19.15% | 1.794B 10.47% | 1.951B 8.87% | 2.079B 8.68% | 2.133B 6.12% | 1.939B 8.08% |
| EBIT Q2Q % growth | 1.438B 14.22% | 1.607B 39.62% | 1.681B 4.54% | 1.459B 83.75% | 1.655B 15.09% | 1.783B 10.95% | 1.836B 9.22% | 1.643B 12.61% |
All data in USD
24 analysts have analysed MMM and the average price target is 177.51 USD. This implies a price increase of 25.72% is expected in the next year compared to the current price of 141.2.
3M CO (MMM) will report earnings on 2026-04-20.
The consensus EPS estimate for the next earnings of 3M CO (MMM) is 2.01 USD and the consensus revenue estimate is 6.11B USD.
The number of analysts covering 3M CO (MMM) is 24.